T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric

See also
Status	Clinical Trial	Phase
Terminated	`NCT00393380` - Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor	Phase 2
Terminated	`NCT00313053` - Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia	Phase 1
Completed	`NCT00483132` - Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III	Phase 3
Recruiting	`NCT04940468` - High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology	N/A
Terminated	`NCT00176930` - Stem Cell Transplant for Hematological Malignancy	N/A
Completed	`NCT00406393` - Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)	Phase 3
Completed	`NCT00246662` - Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies	Phase 1
Terminated	`NCT01100658` - Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors	N/A
Terminated	`NCT00185523` - Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)	Phase 2
Completed	`NCT00905034` - Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage	Phase 2
Recruiting	`NCT00526084` - Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan	N/A
Completed	`NCT00005892` - Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia	N/A
Recruiting	`NCT03544021` - CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）	Phase 1/Phase 2
Terminated	`NCT00176839` - Stem Cell Transplantation for Hematological Malignancies	Phase 2/Phase 3
Not yet recruiting	`NCT05565105` - CD34+ Transplants for Leukemia and Lymphoma	Phase 2
Not yet recruiting	`NCT05154474` - Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
Terminated	`NCT00907517` - Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247)	Phase 1
Terminated	`NCT01050946` - Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit	Phase 2
Completed	`NCT00537550` - Adult ALL Treatment at Diagnosis	N/A
Terminated	`NCT00167180` - Post Transplant Donor Lymphocyte Infusion	Phase 2

NCT number	NCT01078337
Study type	Observational
Source	Stanford University
Contact
Status	Completed
Phase	N/A
Start date	November 2002
Completion date	October 2007

T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms